Anna Szlachcic

1.4k total citations
23 papers, 1.1k citations indexed

About

Anna Szlachcic is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Anna Szlachcic has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Cell Biology and 3 papers in Oncology. Recurrent topics in Anna Szlachcic's work include Fibroblast Growth Factor Research (13 papers), Proteoglycans and glycosaminoglycans research (9 papers) and Heat shock proteins research (5 papers). Anna Szlachcic is often cited by papers focused on Fibroblast Growth Factor Research (13 papers), Proteoglycans and glycosaminoglycans research (9 papers) and Heat shock proteins research (5 papers). Anna Szlachcic collaborates with scholars based in Poland, Germany and United States. Anna Szlachcic's co-authors include Bernd Bukau, Nadinath B. Nillegoda, Jacek Otlewski, D. Lys Guilbride, Matthias P. Mayer, Xuechao Gao, Małgorzata Zakrzewska, Axel Mogk, Marta Carroni and Helen R. Saibil and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Anna Szlachcic

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Szlachcic Poland 13 896 399 159 99 91 23 1.1k
Heidi Olzscha United Kingdom 9 847 0.9× 199 0.5× 200 1.3× 77 0.8× 57 0.6× 15 1.0k
Marilyn Goudreault Canada 16 885 1.0× 585 1.5× 45 0.3× 132 1.3× 35 0.4× 19 1.3k
Rosalie Lawrence United States 10 604 0.7× 350 0.9× 147 0.9× 33 0.3× 64 0.7× 16 1.1k
Daniel Matějů Germany 12 1.5k 1.7× 352 0.9× 54 0.3× 200 2.0× 48 0.5× 14 1.7k
Chrisovalantis Papadopoulos Germany 13 572 0.6× 301 0.8× 170 1.1× 116 1.2× 19 0.2× 14 1.2k
Victoria Menéndez-Benito Sweden 14 898 1.0× 323 0.8× 86 0.5× 60 0.6× 21 0.2× 16 1.1k
Steven Bergink Netherlands 20 1.9k 2.1× 354 0.9× 125 0.8× 93 0.9× 53 0.6× 32 2.1k
Regina‐Maria Kolaitis United States 6 1.3k 1.5× 261 0.7× 52 0.3× 197 2.0× 38 0.4× 7 1.5k
Shoshiro Hirayama Japan 11 527 0.6× 226 0.6× 52 0.3× 48 0.5× 32 0.4× 21 647
Kseniya Petrova United States 7 731 0.8× 412 1.0× 136 0.9× 19 0.2× 33 0.4× 22 1.0k

Countries citing papers authored by Anna Szlachcic

Since Specialization
Citations

This map shows the geographic impact of Anna Szlachcic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Szlachcic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Szlachcic more than expected).

Fields of papers citing papers by Anna Szlachcic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Szlachcic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Szlachcic. The network helps show where Anna Szlachcic may publish in the future.

Co-authorship network of co-authors of Anna Szlachcic

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Szlachcic. A scholar is included among the top collaborators of Anna Szlachcic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Szlachcic. Anna Szlachcic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kocyła, Anna, et al.. (2022). Drug Conjugation via Maleimide–Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 Peptibodies. Molecular Pharmaceutics. 19(5). 1422–1433. 12 indexed citations
3.
Otlewski, Jacek, et al.. (2021). Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent. Frontiers in Pharmacology. 12. 748936–748936. 5 indexed citations
4.
Porębska, Natalia, et al.. (2021). Preparation of Site-Specific Cytotoxic Protein Conjugates via Maleimide-thiol Chemistry and Sortase A-Mediated Ligation. Journal of Visualized Experiments. 2 indexed citations
5.
Szlachcic, Anna, Aleksandra Czyrek, Łukasz Opaliński, et al.. (2019). Low Stability of Integrin-Binding Deficient Mutant of FGF1 Restricts Its Biological Activity. Cells. 8(8). 899–899. 9 indexed citations
6.
Szlachcic, Anna, et al.. (2019). Identification of a peptide antagonist of the FGF1–FGFR1 signaling axis by phage display selection. FEBS Open Bio. 9(5). 914–924. 21 indexed citations
7.
Szlachcic, Anna, et al.. (2018). Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity. International Journal of Molecular Sciences. 19(9). 2470–2470. 9 indexed citations
8.
Szlachcic, Anna, et al.. (2017). Site-specific conjugation of fibroblast growth factor 2 (FGF2) based on incorporation of alkyne-reactive unnatural amino acid. Bioorganic & Medicinal Chemistry. 25(14). 3685–3693. 15 indexed citations
9.
Zakrzewska, Małgorzata, et al.. (2017). High-Yield Site-Specific Conjugation of Fibroblast Growth Factor 1 with Monomethylauristatin E via Cysteine Flanked by Basic Residues. Bioconjugate Chemistry. 28(7). 1850–1858. 19 indexed citations
10.
Kirstein, Janine, Kristin Arnsburg, Annika Scior, et al.. (2017). In vivo properties of the disaggregase function of J‐proteins and Hsc70 in Caenorhabditis elegans stress and aging. Aging Cell. 16(6). 1414–1424. 39 indexed citations
11.
Szlachcic, Anna, et al.. (2016). Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy. Drug Design Development and Therapy. Volume 10. 2547–2560. 27 indexed citations
12.
Kummer, Eva, et al.. (2016). Bacterial and Yeast AAA + Disaggregases ClpB and Hsp104 Operate through Conserved Mechanism Involving Cooperation with Hsp70. Journal of Molecular Biology. 428(21). 4378–4391. 19 indexed citations
13.
Gao, Xuechao, Marta Carroni, Carmen Nussbaum‐Krammer, et al.. (2015). Human Hsp70 Disaggregase Reverses Parkinson’s-Linked α-Synuclein Amyloid Fibrils. Molecular Cell. 59(5). 781–793. 300 indexed citations
14.
Nillegoda, Nadinath B., Janine Kirstein, Anna Szlachcic, et al.. (2015). Crucial HSP70 co-chaperone complex unlocks metazoan protein disaggregation. Nature. 524(7564). 247–251. 269 indexed citations
15.
Szlachcic, Anna, Małgorzata Zakrzewska, & Jacek Otlewski. (2011). Longer action means better drug: Tuning up protein therapeutics. Biotechnology Advances. 29(4). 436–441. 53 indexed citations
16.
Zakrzewska, Małgorzata, Anna Szlachcic, & Jacek Otlewski. (2011). Tailoring Small Proteins Towards Biomedical Applications. Current Pharmaceutical Biotechnology. 12(11). 1792–1798. 2 indexed citations
17.
Makowski, Maciej, et al.. (2010). Two pentadehydropeptides with different configurations of the ΔPhe residues. Acta Crystallographica Section C Crystal Structure Communications. 66(3). o119–o123. 4 indexed citations
18.
Zakrzewska, Małgorzata, Antoni Więdłocha, Anna Szlachcic, et al.. (2009). Increased Protein Stability of FGF1 Can Compensate for Its Reduced Affinity for Heparin. Journal of Biological Chemistry. 284(37). 25388–25403. 47 indexed citations
19.
Mateja, Agnieszka, Anna Szlachcic, Malgorzata Dobosz-Bartoszek, et al.. (2009). The structural basis of tail-anchored membrane protein recognition by Get3. Nature. 461(7262). 361–366. 142 indexed citations
20.
Szlachcic, Anna, Małgorzata Zakrzewska, Daniel Krowarsch, et al.. (2008). Structure of a highly stable mutant of human fibroblast growth factor 1. Acta Crystallographica Section D Biological Crystallography. 65(1). 67–73. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heidi Olzscha Breakdown of academic impact, for papers by Marilyn Goudreault Breakdown of academic impact, for papers by Rosalie Lawrence Breakdown of academic impact, for papers by Daniel Matějů Breakdown of academic impact, for papers by Chrisovalantis Papadopoulos Breakdown of academic impact, for papers by Victoria Menéndez-Benito Breakdown of academic impact, for papers by Steven Bergink Breakdown of academic impact, for papers by Regina‐Maria Kolaitis Breakdown of academic impact, for papers by Shoshiro Hirayama Breakdown of academic impact, for papers by Kseniya Petrova
Rankless by CCL
2026